Pymepharco Joint Stock Company (Công Ty Cổ Phần Pymepharco) (Vietnam)

Pymepharco, operating under the STADA Pymepharco identity, is a Vietnam-based pharmaceutical manufacturer and a wholly owned affiliate of Germany's STADA Group. The company is engaged in the research, manufacture, and commercialization of branded and generic medicines, with product lines spanning prescription and over-the-counter categories. Its portfolio includes antibiotics (notably beta-lactam and non-beta-lactam classes), injectable medicines, solid oral dosage forms, and consumer health products addressing anti-infective, cardiovascular, gastrointestinal, pain management, and respiratory therapy needs. Pymepharco operates large EU-GMP-certified manufacturing complexes in Phu Yen Province with high-capacity tablet, capsule, powder, and sterile injectable lines, enabling supply to hospitals, pharmacies, and health systems across Vietnam. The company distributes nationwide through institutional and retail channels and maintains an export presence to selected international markets supported by global-standard quality certifications. Key assets include its dual manufacturing sites, EU-GMP production lines, R&D and stability-testing laboratories, and a long-standing domestic brand franchise. Strategically, Pymepharco is positioned as one of Vietnam's leading high-quality drug manufacturers, focusing on international-grade compliance, expansion of high-value therapeutic products, and leveraging STADA's global platform for technology transfer and export development.